Best HighYield Savings Account Rates Today Earn Up to 41 APY on May 25 2026
FedExLed Consortium Set to Open 9 Billion Buyout Window for Polish Parcel Firm InPost in Late May
Government Pledges 120 Million to Support UK Ceramics Industry
Consumer Credit Growth Accelerates in December Signaling Strong Spending
SK Hynix Surpasses 1 Trillion Market Cap as AI Demand Drives Chip Rally
Kazatomproms Q3 Output Surges 17 Highlighting Uranium Supply Dynamics
Northern Dynasty Minerals Ltd NAK Q3 2025 Earnings Small Positive EPS Surprise as Pebble Project Advances
VSAT Q1 2026 Earnings Strong EPS Surprise Drives Shares Higher
Falcons Beyond Global FBYD Q1 2026 Earnings Negative EPS Weighs on Shares
CTKB Q1 2026 Earnings EPS Misses Estimates as Operating Losses Widen
SYM Q1 2026 Earnings EPS Misses Estimates by 804 Stock Rallies Despite Setback
MRK Q1 2026 Earnings EPS Surprise on a Loss Stock Declines 22
Eagle Point Credit Notes ECCV Dip Slightly as FixedIncome Market Remains Steady
Gladstone Commercial Preferred Stock GOODO Holds Steady Near Support as YieldSeeking Traders Circle
Navitas Semiconductor NVTS Surges Over 13 as GaN Power Sector Momentum Builds
Endava DAVA Faces Continued Pressure as Shares Slide Over 1
Unum Group UNM Holds Steady Near 84 as Market Weighs Insurance Sector Sentiment
Trump Refiles 10 Billion Lawsuit Against The Wall Street Journal
RNGR Q1 2026 Earnings EPS Miss Weighs on Shares as Revenue Details Remain Unclear
Douglas Emmett DEI Rises Above Key Support A Closer Look at the Regional Office REITs Latest Move
OLB Group Q4 2025 Earnings Narrowed Loss Beats Estimates Shares Rise
CBSH Q1 2026 Earnings EPS Surpasses Expectations by 7 Amid Stable Operations
Park Hotels Resorts Inc PK Q1 2026 Earnings Massive EPS Beat Defies Soft Expectations
EQR Q1 2026 Earnings EPS Misses Estimates as Operating Costs Weigh
AES Q1 2026 Earnings EPS Surges 80 Above Estimates Powered by Strong Execution
American Assets Trust AAT Q1 2026 Earnings EPS Miss of 28 but Shares Edge Higher
Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending